Romosozumab
105mg Pen
Product Details
About This Product
Romosozumab is a monoclonal antibody, not a peptide, and it is unusual in acting on both sides of bone turnover — increasing osteoblast activity while suppressing osteoclasts. That dual action is what distinguishes it in bone density research. Independently verified before release. Laboratory research use only.
Similar Products
Other products in Bone Health
Why Customers Trust SGN
100% Delivery Guarantee
If your package is seized or lost in transit, we reship at no extra cost — no questions asked.
60-Day Refund Policy
Not satisfied? Get a full refund, free replacement, or 110% store credit within 60 days.
Secure Payment Processing
256-bit encrypted checkout via Visa, Mastercard, Apple Pay, Google Pay, and crypto.
Discreet Packaging
Plain, unmarked packaging with no product labels or company branding visible.
4,800+ Verified Reviews
Real customer feedback — read reviews
Tracked Shipping Worldwide
Every order includes a tracking number. Express shipping available (3-6 days).
4 Labs · 99.5%+ Purity
Verified by Janoshik, Medutest, PeptideMeter & VendorInvestigate — view this product's test reports
Factory Direct
Direct from Sangon Biotech (Shanghai) Co., Ltd.
Multiple Payment Methods
Visa, MC, Apple Pay, Google Pay, Bank Transfer, Crypto
24/7 Support
Reach out anytime via email